Preventing malaria by removing proteins
Researchers from the Walter and Eliza Hall Institute (WEHI) have shown that the malaria parasite cannot penetrate a human red blood cell when key proteins are deleted.
Their study, published in the journal Cell Host & Microbe, gives fresh hope to the development of much-needed new antimalarial treatment, with existing drugs becoming less effective as the parasite develops resistance.
Professor Alan Cowman and his team at WEHI discovered that three proteins known as Rh5, Ripr and CyRPA together form a complex that plays a vital role in the ability of the Plasmodium falciparum parasite to invade healthy human blood cells. In a study that effectively removed or ‘knocked out’ the Ripr or CyRPA proteins, the malaria parasite was unable to invade the red blood cell, stopping infection.
“These findings hold great promise for understanding the function of these proteins and their development as vaccines,” said Professor Cowman, adding that the development of new vaccines for malaria is a global research priority.
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
